Healthcare -
Biotechnology - NASDAQ - US
$ 1.045
-6.7 %
$ 119 M
Market Cap
-0.64
P/E
FATE - NET CHANGE IN CASH
Net Change in Cash FATE - Fate Therapeutics, Inc.
-19.5 M
LAST VALUE
23.98%
2 YEAR CAGR
-3.57%
5 YEAR CAGR
-3.67%
10 YEAR CAGR